2025.04.27 (일)

  • 구름많음동두천 19.6℃
  • 구름많음강릉 24.0℃
  • 흐림서울 18.8℃
  • 구름많음대전 24.3℃
  • 구름많음대구 25.8℃
  • 구름많음울산 26.4℃
  • 구름많음광주 24.1℃
  • 구름많음부산 20.2℃
  • 구름많음고창 23.4℃
  • 흐림제주 20.4℃
  • 구름많음강화 14.8℃
  • 구름많음보은 22.5℃
  • 구름많음금산 23.5℃
  • 흐림강진군 24.6℃
  • 구름많음경주시 27.5℃
  • 구름많음거제 21.3℃
기상청 제공

경제

Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index

[By NBC-1TV H. J Yook]Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it has been selected for addition to the NASDAQ Biotechnology Index ® (Nasdaq:^NBI), effective prior to the market open on Monday, May 20.

The NASDAQ Biotechnology Index is designed to track the performance of a set of NASDAQ-listed securities classified according to the Industry Classification Benchmark (ICB) as either Biotechnology or Pharmaceuticals. These companies must meet eligibility criteria that include a minimum market capitalization of $200 million and minimum average daily trading volume of 100,000 shares, amongst other requirements. The Index Securities are evaluated semi-annually in May and November and serve as the basis for the iShares NASDAQ Biotechnology Index Fund (Amex:IBB). For more information about the NASDAQ Biotechnology Index, including eligibility criteria, visit www.nasdaq.com.



배너

관련기사


배너
배너
배너
배너
배너
배너
배너
배너
배너
배너
배너
배너